Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary patch technology that simplifies and improves the way actives are delivered, stored, and distributed. This technology is designed to increase patient access to drugs and vaccines that would otherwise require expert injection and to improve safety and efficacy by skin targeting.
Technology - Micron Biomedical
China tells tech manufacturers to stop using Micron chips
Micron Biomedical, Inc. Email Format
Micron Biomedical Inc. Atlanta, GA, US Startup
Micron Biomedical Inc. Atlanta, GA, US Startup
Micron Biomedical, Inc. Overview
Atlanta Inno - FormD Friday: OMNY Inc. leads Atlanta startup
Microneedle Flu Vaccine Market 2023-2030 – Global Strategic
Micron Proudly Reports 50% Gender Representation on Board of Directors
Steven Damon - Micron Biomedical